29. Factors predicting the probably to attain the target of initial vancomycin trough level in treatment of pneumococcal meningitis

Dao Huu Nam, Nguyen Van Lam, Nguyen Thi Huyen, Dang Phuong Thuy

Main Article Content

Abstract

Vancomycin is an antibiotic that plays an important role in the treatment of pneumococcal meningitis. In order to have the scientific basis and necessary data to establish an optimal dose regimen for children with pneumococcal meningitis, we conducted this study with goals “To investigate the vancomycin concentration and factors predicting the probably to attain the trough concentration target at the first measurement in treatment of pneumococcal meningitis”. Retrospective, cross-sectional study on 37 cases of pneumococcal meningitis, whose were monitored the vancomycin serum level at the Center for Tropical Diseases, National Children’s Hospital since July 2020 to July 2022. The proportion of patients who reached target trough levels at the first measurement was 24.3%. Univariate analysis of factors associated with subtherapeutic trough levels showed that age group, renal function, shock on admission are statistically significant factors. Conclusion: Vancomycin dose of 60 mg/kg/day is insufficient to attain target trough levels for most of the children having pneumococcal meningitis. Patients with shock on admission have a lower risk of subtherapeutic trough concentrations than patients without shock.

Article Details

References

1. Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. The Journal of infection. 2016;73(1):18-27. doi: 10.1016/j.jinf.2016.04.009.
2. Torumkuney D, Van PH, Thinh LQ, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. The Journal of antimicrobial chemotherapy. 2020;75(Suppl 1):i19-i42. doi: 10.1093/jac/dkaa082.
3. Kimberlin DW, Brady MT, Jackson MA, et al. Red Book (2018): Report of the Committee on Infectious Diseases. Chap Pneumococcal Infections. 2018:639-650.
4. Bệnh viện Nhi Trung ương. Quy trình kỹ thuật Theo dõi nồng độ vancomycin trong máu (2020).
5. Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. American journal of health-system pharmacy. 2020;77(11):835-864.
6. Salem M, Khalil A, Mohamed A, et al. Evaluation of vancomycin initial trough levels in children: A 1-year retrospective study. SAGE Open Medicine. 2020;8:2050312120951058.
7. Madigan T, Sieve RM, Graner KK, et al. The effect of age and weight on vancomycin serum trough concentrations in pediatric patients. Pharmacotherapy. 2013;33(12):1264-72.
8. Rainkie D, Ensom MH, Carr R. Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): A retrospective review. Paediatric drugs. 2015;17(3):245-53.
9. Trịnh Thị Vân Anh, Bùi Thị Ngọc Thực, Nguyễn Hoàng Anh, và cs. Phân tích kết quả hiệu chỉnh liều vancomycin thông qua giám sát nồng độ thuốc trong máu bằng phương pháp ước đoán AUC theo Bayes tại Trung tâm Nhi khoa, Bệnh viện Bạch Mai. Tạp chí Nghiên cứu Dược và Thông tin thuốc. 2022;13(1):1-8.
10. Maloni TM, Belucci TR, Malagutti SR, et al. Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met. BMC pediatrics. 2019;19(1):240.
11. Phạm Thu Hà, và cs. Phân tích đặc điểm giám sát nồng độ vancomycin trong máu trên bệnh nhân nhi điều trị tại khoa Điều trị tích cực Nội, Bệnh viện Nhi Trung Uơng. Tạp chí Y Dược học. 2021;26:4-10.
12. Sridharan K, Al-Daylami A, Ajjawi R, et al. Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital. Paediatric drugs. 2019;21(4):303-312.
13. Kondo M, Nakagawa S, Orii S, et al. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection. Biological & pharmaceutical bulletin. 2020;43(10):1463-1468. doi: 10.1248/bpb.b19-01003.
14. He CY, Ye PP, Liu B, et al. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance. Antimicrob Agents Chemother. 2021;65(10):e0089721. doi: 10.1128/aac.00897-21.
15. Issaranggoon Na Ayuthaya S, Katip W, et al. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC(24)) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;92:151-159.